Skip to main content

Table 1 Patient characteristics at the year 1 assessment: data is presented for all patients and sub-divided by exacerbation category in year 1 of follow-up

From: Factors associated with change in exacerbation frequency in COPD

 

All COPD (n=1832)

FE (n=543)

IE (n=1289)

p-value FE v IE

Age (years)

64 (7)

64 (7)

64 (7)

0.751

Females (%)

35%

41%

32%

<0.001

BMI (kg/m2)

27 (6)

26 (6)

27 (6)

0.006

Active smoker (%)

36%

33%

37%

0.113

*FEV1 (L)

1.37 (0.55)

1.14 (0.45)

1.47 (0.55)

<0.001

*FEV1 %predicted

49 (16)

43 (16)

52 (16)

<0.001

*FEV1/FVC %

45 (12)

41 (12)

46 (12)

<0.001

6-minute walk distance (m)

385 (123)

350 (119)

399 (122)

<0.001

%predicted 6MWD

74 (24)

69 (23)

77 (23)

<0.001

Blood oxygen saturation (%)

94.7 (2.9)

94.2 (3.1)

94.9 (2.8)

<0.001

Emphysema LAA% (-950HU)

18 (12)

20 (13)

17 (12)

<0.001

mMRC Dyspnoea Score

1.7 (1.1)

2.0 (1.1)

1.5 (1.0)

<0.001

SGRQ-C Total Score

47 (21)

57 (18)

43 (21)

<0.001

BODE Index

3.0 (2.1)

3.9 (2.2)

2.7 (2.0)

<0.001

White blood cells (10^9/L)

7.6 (2.2)

8.1 (2.4)

7.4 (2.0)

<0.001

Platelets (10^9/L)

266 (71)

276 (75)

261 (69)

0.002

Fibrinogen (mg/dL)

436 [383–504]

468 [405–535]

426 [376–492]

<0.001

CRP (mg/dL)

3.3 [1.5-7.3]

4.1 [1.8-9.1]

3.1 [1.4-6.6]

<0.001

SP-D (ng/mL)

119 [87–163]

115 [86–159]

121 [87–166]

0.294

PARC/CCL-18 (ng/mL)

112 [87–145]

119 [92–154]

111 [85–141]

0.001

Neutrophils (10^9/L)

5.0 (1.9)

5.4 (2.2)

4.8 (1.8)

<0.001

Treated with ICSL %

71%

81%

66%

0.159

Treated with LAMA %

63%

68%

60%

<0.001

Treated with ICS %

17%

15%

17%

0.336

Treated with LABA %

14%

14%

15%

0.813

Treated with Oxygen %

10%

16%

6%

<0.001

PPPY COPD Hosp. Year 1

0.20

0.55

0.05

<0.001

PPPY OCS only exbs Y1

0.13

0.35

0.04

<0.001

Diabetes

10%

8%

10%

0.287

Cardiovascular (excl. HTN)

33%

32%

33%

0.868

Reflux/heartburn

26%

33%

23%

<0.001

Anxiety

16%

21%

14%

<0.001

Depression symptoms

25%

33%

21%

<0.001

  1. P-values are for comparisons between patients with Frequent (FE) and Infrequent exacerbations (IE). Mean (SD) or Median [25% - 75% percentile].